A client is admitted with bipolar disorder and lithium carbonate is prescribed. Before administering the daily dose, the practical nurse (PN) plans to monitor the client’s serum lithium levels. Which physiologic action necessitates frequent monitoring of serum lithium levels?
Serum levels reflect client compliance and support behavior changes
Sodium influences a narrow margin between therapeutic and toxic levels
Myelosuppression and agranulocytosis are common side effects
Foods containing tyramine influence the drug’s metabolism
The Correct Answer is B
Choice A reason: Serum lithium levels indicate compliance but do not directly explain the need for frequent monitoring. Lithium’s therapeutic effect stabilizes mood, but monitoring is primarily due to its narrow therapeutic index, where small changes in blood levels can cause toxicity, not just behavioral changes or compliance.
Choice B reason: Sodium levels affect lithium excretion, as both compete for renal reabsorption. Low sodium increases lithium retention, risking toxicity, while high sodium increases excretion, reducing efficacy. Lithium’s narrow therapeutic range (0.6–1.2 mEq/L) necessitates frequent monitoring to prevent toxic levels, which can cause neurological or cardiac issues.
Choice C reason: Myelosuppression and agranulocytosis are not common lithium side effects. Lithium may cause mild leukocytosis, not suppression. Toxicity risks, like neurological or renal effects, drive monitoring needs, not hematologic issues. This choice is incorrect, as it misrepresents lithium’s side effect profile.
Choice D reason: Tyramine, relevant to monoamine oxidase inhibitors, does not influence lithium metabolism. Lithium’s pharmacokinetics are affected by sodium and renal function, not dietary tyramine. This choice is incorrect, as it falsely links a dietary factor to lithium’s monitoring requirements.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Cephalexin, a cephalosporin, has a 5–10% cross-reactivity risk with penicillin allergies due to similar beta-lactam structures. An anaphylactic history increases the risk of severe reactions. Contacting the provider ensures safety, potentially leading to an alternative antibiotic to prevent life-threatening allergic responses.
Choice B reason: Monitoring for rash or hives is reactive and insufficient for a client with a penicillin anaphylaxis history. Cephalexin’s cross-reactivity risk requires proactive avoidance, not just observation, as anaphylaxis can occur rapidly, making this choice inadequate compared to provider consultation.
Choice C reason: Giving cephalexin with an antihistamine does not prevent anaphylaxis, which can be rapid and severe in penicillin-allergic clients. Antihistamines mitigate mild allergies but are ineffective against severe reactions. This choice is unsafe without confirming the drug’s appropriateness first.
Choice D reason: Administering cephalexin as prescribed ignores the significant risk of cross-reactivity with penicillin, given the client’s anaphylactic history. This could trigger a life-threatening reaction, as cephalosporins share structural similarities with penicillins, making immediate administration without verification dangerous.
Correct Answer is C
Explanation
Choice A reason: Less frequent urinary incontinence is a desired effect of oxybutynin, an antimuscarinic that relaxes bladder muscles, reducing involuntary contractions. This indicates therapeutic success in managing overactive bladder, not a concern requiring reporting, as it aligns with the drug’s intended action.
Choice B reason: Diminished urinary urgency is an expected outcome of oxybutynin, which inhibits bladder spasms by blocking acetylcholine receptors. This reduces the urge to urinate, improving overactive bladder symptoms, and does not warrant reporting, as it reflects the medication’s efficacy.
Choice C reason: Decreased urinary output is concerning, as oxybutynin’s anticholinergic effects may cause urinary retention by overly relaxing the bladder. This risks bladder distension or infection, requiring reporting to assess for obstruction or adjust dosing, making this the critical finding to address.
Choice D reason: Reduced urinary frequency is a therapeutic effect of oxybutynin, which decreases bladder contractions, allowing longer intervals between urination. This is a goal of overactive bladder treatment and does not require reporting, as it indicates the drug is working as intended.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.